Thalidomide Reduces Vascular Endothelial Growth Factor Immunostaining in Canine Splenic Hemangiosarcoma

Hemangiosarcomas (HSA) are common neoplasms of dogs that often metastasize and are typically fatal. Recently it was demonstrated that thalidomide extends the survival time of dogs with HSA, potentially due to thalidomide-induced inhibition of vascular endothelial growth factor (VEGF) production by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bray, Jonathan P., Munday, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355933/
https://www.ncbi.nlm.nih.gov/pubmed/32443710
http://dx.doi.org/10.3390/vetsci7020067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355933/
https://www.ncbi.nlm.nih.gov/pubmed/32443710
http://dx.doi.org/10.3390/vetsci7020067

Ejemplares similares